Focal Therapy Clinical Trials - Concepts and Challenges with Dr. Frank

16 Visioni

  • Grazie! Condividilo con i tuoi amici!

    Non hai gradito questo video. Grazie per il feedback!

admin
Published
Steven J. Frank, MD, FACR, FABS, FASTRO, Professor of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, explores the complexities and evolving landscape of focal therapy for prostate cancer. In this 15-minute presentation, Dr. Frank emphasizes clinical challenges, treatment outcomes, and the role of radiation approaches.

Dr. Frank underscores that while imaging advancements such as PSMA PET and MRI improve lesion identification, focal therapy remains a non-standard approach within current guidelines. Studies evaluating various focal therapy modalities, including HIFU, cryoablation, and focal brachytherapy, demonstrate inconsistent biochemical control rates and frequent PSA fluctuations.

Radiation strategies such as brachytherapy have shown some success in salvage settings, where precise targeting of dominant lesions can improve outcomes. However, the data suggests that single-fraction treatments may be insufficient.

Dr. Frank asserts that focal therapy is best considered in recurrent disease scenarios rather than as a primary treatment for localized prostate cancer. Greater standardization in treatment protocols, improved definitions of biochemical success, and robust clinical trials comparing focal therapy against established methods are essential to clarify its role in prostate cancer management.

Don't forget to join the GRU Community: https://grandroundsinurology.com/register/
Follow us on Twitter/X: https://x.com/GRUrology
And like and subscribe to us here on YouTube!
Categoria
Oncology
Commenta per primo questo video.

Prossimo